Clarity Pharmaceuticals Health Care

$0.700 0.005 (0.72%)

High $0.72	Low $0.70	Trades 33	Turnover $39,512	Volume 56,305
30 June 2023 at 4:10pm

Register to track CU6 and receive email alerts.

Market Cap (19-Sep) $827,996,160 (700th)	Close (30-Jun) $0.70 0 (0%)	Volume (30-Jun) 56,305	Shortsold (26-May) 28,715,960 (7.70%) (37th)
52w High $5.87	52w Low $1.97	P/E -	EPS -0.28

	Subject
	CU6 CU6 Ann: Clarity confirms no supply issues to its clinical trials
	1 (current) 2 3
	CU6 CU6 Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: First patient treated in the prostate cancer imaging trial
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Notification of cessation of securities - CU6
	CU6 CU6 Ann: Appointment of CFO
	CU6 CU6 Ann: COBRA trial in prostate cancer opens for recruitment
	CU6 CU6 Ann: New clinical trial collaboration in prostate cancer
	CU6 CU6 Ann: Clarity - Investor Presentation 03-03-2022
	CU6 CU6 Ann: Clarity Half Yearly Report
	CU6 CU6 Ann: Half Year Accounts
	CU6 CU6 Ann: Update on China Grand Pharmaceutical and Healthcare Holdings
	CU6 CU6 Ann: First patient treated in cohort 2 neuroblastoma trial
	CU6 CU6 Ann: Release of Securities from Escrow
	CU6 CU6 Ann: US FDA Study May Proceed letter for Cu-64 SAR-bisPSMA
	CU6 CU6 Ann: Clarity receives $3.26 million R&D tax incentive refund
	CU6 CU6 Ann: Response to media reports of shortages of medical isotopes
	CU6 CU6 Ann: SARTATE Neuroblastoma trial advances to cohort 2
	CU6 CU6 Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Becoming a substantial holder
	CU6 CU6 Ann: Change of Director's Interest Notice - Biggin
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Becoming a substantial holder
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Release of Securities from Escrow
	CU6 CU6 Ann: Clarity and Cardinal Health enter into Agreement for TCT
	CU6 CU6 Ann: Fifty percent recruitment milestone for PROPELLER trial
	CU6 CU6 Ann: Clarity strengthens patent protection of SAR-bisPSMA
	CU6 CU6 Ann: Results of Meeting
	CU6 CU6 Ann: Managing Directors Presentation to Annual General Meeting
	CU6 CU6 Ann: Chairman's Address to Shareholders
	CU6 CU6 Ann: Quarterly Activity Report
	CU6 CU6 Ann: Clarity Presentation for Bell Potter Healthcare conference
	CU6 CU6 Ann: Dosimetry Recruitment of theranostic prostate trial complete
	CU6 CU6 Ann: Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Notice of Annual General Meeting/Proxy Form
	CU6 CU6 Ann: Annual Report to shareholders
	CU6 CU6 Ann: Recruitment closed on C-BOBCAT SAR-Bombesin trial
	CU6 CU6 Ann: Manufacturing agreement for Clarity's US clinical trials
	CU6 CU6 Ann: Notice of Annual General Meeting
	CU6 CU6 Ann: Clarity joins the CORAR
	CU6 CU6 Ann: Release of securities from escrow
	CU6 CU6 Ann: Becoming a substantial holder - GenesisCare
	CU6 CU6 Ann: Company Briefing
	CU6 CU6 Ann: Becoming a substantial holder - Taylor
	CU6 CU6 Ann: Becoming a substantial holder - Morgan

Register to track CU6 and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$3.53	1,598,701	+0.29 (8.95%)
12-Sep	$3.24	1,527,582	+0.11 (3.51%)
11-Sep	$3.13	1,661,390	-0.04 (1.26%)
05-Sep	$3.17	1,197,820	+0.04 (1.28%)
04-Sep	$3.13	1,687,219	+0.03 (0.97%)
03-Sep	$3.10	2,046,917	+0.12 (4.03%)
29-Aug	$2.98	4,850,945	-0.20 (6.29%)
28-Aug	$3.18	2,981,913	-0.21 (6.19%)
22-Aug	$3.39	2,593,743	-0.15 (4.24%)
21-Aug	$3.54	2,763,175	-0.12 (3.28%)
15-Aug	$3.66	1,744,649	+0.04 (1.10%)
14-Aug	$3.62	2,810,384	-0.76 (17.35%)
07-Aug	$4.38	4,185,588	+0.01 (0.23%)
31-Jul	$4.37	3,417,626	+0.04 (0.92%)
30-Jul	$4.33	2,723,736	0.00 (0.00%)
8 up, 6 down, and 1 flat days